The least useful question about any new allocation is “what should this replace?” The useful question is the one allocators actually ask: what job in the portfolio is currently unfilled? This article is about one specific job — return that does not take its instructions from the macro — and how sophisticated investors think about sizing a sleeve built to do it. It is a description of reasoning, not a recommendation; sizing decisions belong to you and your advisers.
The job became visible to everyone in 2022, when equities and bonds fell together and the classic 60/40 had its worst stretch in decades. The lesson wasn't that diversification failed — it's that diversification within macro-priced assets converges exactly when it's needed most. Stocks, bonds, real estate, private equity, credit: different wrappers, same inputs. When rates, war, and supply chains reprice one, they reprice all.
This is why the distinction between statistical and structural uncorrelation matters more than any backtest. Most alternatives are statistically uncorrelated — until stress arrives and the correlations climb. Sports outcomes sit outside the macro by construction: a final score is not an earnings call, and no rate decision changes who won the game. That structural property is the entire reason BettorToken exists. It is also not a guarantee of anything — uncorrelated does not mean risk-free, and an uncorrelated asset can still lose money on its own terms.
The sleeve logic follows from the structure. Allocators who hold uncorrelated exposures typically treat them as a satellite — sized so that the exposure's specific risks are survivable even in a bad outcome. For our offerings, those specific risks are stated plainly in our Operator's Note: a twelve-month operating record that is not yet a track record, an attestation engaged but unfinished, an unsecured note, a first-time issuer. Anyone sizing a position as though those risks didn't exist is sizing it wrong, and we say so in our own materials.
Within the sleeve, the two instruments do different jobs. FYN is defined-term credit exposure — twelve months, fixed yield, a contractual obligation that exists independent of platform performance, carrying issuer credit risk in exchange. SPLT is direct participation — five years, NAV-linked, value moving with the platform's performance year by year. Some investors hold one; some hold both in different proportions; the routing question is whether the mandate is income certainty or aligned upside.
Just as important is what disqualifies the sleeve entirely. Capital needed within twelve months has no business here — the terms are 365 days and five years by design. Mandates restricted to investment-grade credit should treat FYN accordingly and likely pass. And anyone seeking a guarantee should leave this category altogether, ours included, because nobody honest in it sells one.
For many readers, the right size for this sleeve today is zero — with a calendar note to revisit when FY2 data has had time to accumulate. We publish that data as it settles precisely so that the patient version of this decision is possible. Read the risk factors first. Then, if the job we've described is genuinely unfilled in your book, that's the conversation worth having.